Anticoagulation in patients with atrial fibrillation. Underuse of warfarin is multifactorial.
Authors:
- L DowLDL Dow
- B BertagneBBB Bertagne
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Survey of use of anticoagulation in patients with atrial fibrillation.BMJ, 1993
- Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ, 1992
- Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)BMJ, 1992
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 1992
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJACC, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTSAge and Ageing, 1988